NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/15/2025
Back to search
Official data from USPTO
IMMULAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/16/2025
Trademark type
Combined
Nice classes
1, 5
Filing date
10/04/2021
Registration date
01/10/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/10/2023
Last transaction
08/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
AU
Examiner
SINGH, TEJBIR
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of of the wording IMMULAB, with two dots over the letter I in blue, with LAB in blue, and with IMMU in gray. To the right is a black, gray, and blue butterfly.
Holders and representatives
Holders
Immulab Pty Ltd
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biological reagents for non-medical purposes; chemical test kits comprised of chemical preparations for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific and/or industrial purposes; diagnostic and chemical reagents for testing for scientific and research purposes; chemical and biological reagents for non-medical purposes; chemical and biological reagents for anti-body screeningblood groupingfor the typing and detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypesall the aforesaid being for scientific and research purposes; chemical test kits for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for anti-body screeningblood groupingthe typing and detection of specific blood cells for scientific and research purposes
Class 5
Pharmaceutical preparations and substancesblood grouping serums and blood typing serumsmedical reagents and assays for testing blood to determine blood type; blood components for medical purposesplateletsplasma and red blood cells; pharmaceutical test kits in this classbeing for diagnostic medical purposesdiagnostic test kits comprised of medical diagnostic reagents and assays for clinical laboratory use in use in blood grouping and antibody screening; blood products for medical purposesblood plasmareagent blood cells; reagents for medical usereagents for the typing and detection of specific blood cellsthe detection of relevant compliment components and immunoglobulin subtypes; clinical medical reagents for the typing and detection of specific blood cellsthe detection of relevant compliment components and immunoglobulin subtypes; pharmaceutical preparationsreagent red blood cells used for quality control in immunohematology tests to detect antibodies or immunoglobulin subtypes; diagnostic reagents for medical or veterinary use; pharmaceutical preparationsreagent red blood cells for medical use and medical testing used to detect antibodies or immunoglobulin subtypes; test kits comprised of medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; biological reagents for medical use
Publications
History of USPTO decisions and trademark events.
23 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/17/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/26/2023
FIMP
FINAL DISPOSITION PROCESSED
04/26/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/10/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2022
PUBO
PUBLISHED FOR OPPOSITION
10/25/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/25/2022
RFNT
REFUSAL PROCESSED BY IB
08/23/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/29/2022
RFRR
REFUSAL PROCESSED BY MPU
07/29/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/08/2022
CNRT
NON-FINAL ACTION WRITTEN
07/07/2022
DOCK
ASSIGNED TO EXAMINER
07/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/24/2022
Continuous trademark protection
Get notified about every new filing that threatens IMMULAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.